Biotech cluster focused on innovation in gene therapy
Asklepios BioPharmaceutical, Inc. (AskBio) is a leading clinical-stage adeno-associated virus (AAV) gene therapy company dedicated to improving the lives of patients with rare disorders and other diseases. It has built a foundation of therapeutic programmes, AAV manufacturing and a rich portfolio of proprietary technology. Its therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases, with ongoing clinical trials for Pompe disease, Parkinson’s disease and congestive heart failure.
CEO: Sheila Mikhail and Jude Samulski.
2016-2020 (Sold to Bayer)
20 T.W. Alexander Drive
Research Triangle Park, NC 27709.